Idraparinux(sanorg 34006)for treatment and secondary prophylaxis of venous thromboemolic events in patients with deep venous thrombosis

Details for Australian Patent Application No. 2003205664 (hide)

International Classifications

Event Publications

17 July 2003 Complete Application Filed

Priority application(s): 002075374.5 29.01.02 EP

18 September 2003 Application Open to Public Inspection

Published as AU-B-2003205664

17 February 2005 Change of Name(s) of Applicant(s), Section 104

Sanofi-Synthelabo The name of the applicant has been changed to Sanofi-Aventis

5 June 2008 Application Accepted

Published as AU-B-2003205664

2 October 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.